Literature DB >> 16673413

Inactivation of herpes simplex type 1 gene vector on immobilized metal affinity chromatography: oxidative damage by hydroxyl free radicals and its prevention.

Canping Jiang1, Mohammad Ataai, Ali Ozuer, David Krisky, James Wechuck, Soraya Pornsuwan, Fazard Pourarian, Joseph C Glorioso.   

Abstract

Metal catalyzed oxidation (MCO), which typically involves oxygen free radical generation, is an important pathway that leads to the deterioration of many biological molecules in solution. The occurrence of MCO in immobilized metal affinity chromatography (IMAC) systems and its potential for inactivating biological products has not been well recognized. In this study, we report the inactivation of herpes simplex virus type 1 (HSV-1) gene therapy vector on immobilized cobalt affinity chromatography. We observed that purification of KgBHAT, an HSV-1 mutant bearing cobalt affinity tags (HAT) on the surface, on an IDA-Co2+ column using crude supernatant as starting material resulted in signification loss in virus infectivity (<5% recovery). Electron spin resonance (ESR) revealed that the virus inactivation was caused by hydroxyl free radicals generated from the interactions between cellular impurities and the metal ions on the column. Inclusion of 20 mM ascorbate, a free radical scavenger, in the chromatography mobile phase effectively scavenged the hydroxyl radicals and dramatically augmented the infectivity recovery to 70%. This finding is the first demonstration of oxygen free radical-mediated biological inactivation in an actual IMAC purification and the way on how to effectively prevent it. (c) 2006 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16673413     DOI: 10.1002/bit.20943

Source DB:  PubMed          Journal:  Biotechnol Bioeng        ISSN: 0006-3592            Impact factor:   4.530


  6 in total

1.  Bispecific adapter-mediated retargeting of a receptor-restricted HSV-1 vector to CEA-bearing tumor cells.

Authors:  Hyunjung Baek; Hiroaki Uchida; Kyungok Jun; Jae-Hong Kim; Masahide Kuroki; Justus B Cohen; Joseph C Glorioso; Heechung Kwon
Journal:  Mol Ther       Date:  2010-10-05       Impact factor: 11.454

2.  Generation of herpesvirus entry mediator (HVEM)-restricted herpes simplex virus type 1 mutant viruses: resistance of HVEM-expressing cells and identification of mutations that rescue nectin-1 recognition.

Authors:  Hiroaki Uchida; Waris A Shah; Ali Ozuer; Arthur R Frampton; William F Goins; Paola Grandi; Justus B Cohen; Joseph C Glorioso
Journal:  J Virol       Date:  2009-01-07       Impact factor: 5.103

3.  A double mutation in glycoprotein gB compensates for ineffective gD-dependent initiation of herpes simplex virus type 1 infection.

Authors:  Hiroaki Uchida; Janet Chan; William F Goins; Paola Grandi; Izumi Kumagai; Justus B Cohen; Joseph C Glorioso
Journal:  J Virol       Date:  2010-09-22       Impact factor: 5.103

4.  Evaluation of parameters for efficient purification and long-term storage of herpes simplex virus-based vectors.

Authors:  Seiji Kuroda; Yoshitaka Miyagawa; Makoto Sukegawa; Taro Tomono; Motoko Yamamoto; Kumi Adachi; Gianluca Verlengia; William F Goins; Justus B Cohen; Joseph C Glorioso; Takashi Okada
Journal:  Mol Ther Methods Clin Dev       Date:  2022-06-13       Impact factor: 5.849

5.  Novel mutations in gB and gH circumvent the requirement for known gD Receptors in herpes simplex virus 1 entry and cell-to-cell spread.

Authors:  Hiroaki Uchida; Janet Chan; Indira Shrivastava; Bonnie Reinhart; Paola Grandi; Joseph C Glorioso; Justus B Cohen
Journal:  J Virol       Date:  2012-11-14       Impact factor: 5.103

6.  High-purity preparation of HSV-2 vaccine candidate ACAM529 is immunogenic and efficacious in vivo.

Authors:  Sophia T Mundle; Hector Hernandez; John Hamberger; John Catalan; Changhong Zhou; Svetlana Stegalkina; Andrea Tiffany; Harry Kleanthous; Simon Delagrave; Stephen F Anderson
Journal:  PLoS One       Date:  2013-02-26       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.